Encouragingly, both inhibitors led to a significant decrease in colony-forming activity in vitro and increased the survival in vivo, with pre-BCR+ leukaemia cells being more sensitive to A-770041 and P505-15 compared with pre-BCR− leukaemia cells. Here, BCR is linked to leukemia.